Boyle A. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes. THU-285.
Off-target antilichaamrespons malariavaccin leidt tot brede bescherming
jun 2022 | Parasitaire infecties, Vaccinatie